Individually Targeted Neuromodulation for Contamination-based OCD
RecruitingNCT05048251Phase: NAStarted 2022-07-01
Summary
Patients with obsessive-compulsive disorder (OCD) experience a wide array of different types of obsessions and compulsions. However, current treatments for OCD employ a "one size fits all" approach an
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
55 Years
Locations
McLean HospitalBelmont, Massachusetts, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05048251